CCR Connections, Volume 6, No.1, 2012

First Page		Document Content
Date: 2014-01-16 14:41:10 Anti-CD22 immunotoxin Hematology Ira Pastan Immunotoxin Cancer organizations Hairy cell leukemia Neuroblastoma CD22 Cancer research Medicine Oncology Brain tumor		CCR Connections, Volume 6, No.1, 2012 Add to Reading List Source URL: home.ccr.cancer.gov Download Document from Source Website File Size: 1,56 MB Share Document on Facebook

	Induction of Tolerance to Immunotoxins Using Nanoparticle Delivery of Rapamycin Ronit Mazor and Ira Pastan Immunogenicity summit October 2016 DocID: 1uGDJ - View Document
	f e a t u r e All in Good Fun DocID: JoQ5 - View Document
	A Better Immunotoxin Through inspired engineering, proteins that enter and kill cancer cells are finding their place among cancer treatments. (Photo: R. Baer) DocID: Gf5A - View Document
	f e a t u r e Precision in Targeting with Anti-Mesothelin Therapies For two decades, Raffit Hassan, M.D., Co-Chief of CCR’s Thoracic and Gastrointestinal Oncology DocID: C35z - View Document
	f e a t u r e Precision in Targeting with Anti-Mesothelin Therapies For two decades, Raffit Hassan, M.D., Co-Chief of CCR’s Thoracic and Gastrointestinal Oncology DocID: AXqR - View Document